Oxbryta Lawsuit
Pfizer has recently issued a global recall of Oxbryta, a medication to treat the symptoms of sickle cell disease. Prescribed Oxbryta? We can Help!
Oxbryta Lawsuit: Seeking Justice for Sickle Cell Patients
Pfizer recently announced a global recall of Oxbryta, a medication developed to manage symptoms of sickle cell disease (SCD). Alarmingly, new studies indicate that instead of providing relief, Oxbryta may increase the risk of severe complications, including vaso-occlusive crises (VOCs) and even fatalities. Shamis Gentile is currently representing affected patients in legal action against Pfizer.
If you or a loved one took Oxbryta and experienced worsening symptoms or serious side effects, you may be entitled to compensation. Our attorneys are committed to holding Pfizer accountable and fighting for the recovery you deserve.
What is Oxbryta?
Oxbryta (voxelotor) was introduced as an innovative treatment for sickle cell disease, aimed at improving hemoglobin's ability to bind oxygen and reducing red blood cell sickling. Approved by the FDA in 2019, the drug was initially seen as a significant advancement for individuals living with SCD. However, subsequent studies revealed that the risks of Oxbryta often outweigh its benefits.
Patients taking Oxbryta reported a higher incidence of severe complications, such as VOCs, which can lead to life-threatening outcomes. Sickle cell patients placed their trust in Oxbryta to manage their condition, yet Pfizer's failure to fully disclose its risks has caused unnecessary suffering. Shamis Gentile is dedicated to helping victims seek justice and obtain fair compensation for their hardships.
Health Risks Associated with Oxbryta
How We Can Help
Shamis Gentile PA is leading legal efforts against Pfizer, representing individuals harmed by Oxbryta's side effects. We believe Pfizer did not adequately test Oxbryta or disclose the significant risks it posed to vulnerable SCD patients. Our legal team is working tirelessly to hold Pfizer accountable and secure compensation for those affected.
Victims of Oxbryta may qualify for compensation covering:
What We Know About Pfizer's Oxbryta
Pfizer's Oxbryta was heralded as a breakthrough treatment for sickle cell disease. However, the medication has become the center of multiple lawsuits and investigations:
Taking Action
If you or a family member suffered adverse effects from Oxbryta, including the development or worsening of vaso-occlusive crises, our legal team is ready to help. We understand the pain and frustration of trusting a medication that turned out to be harmful, and we are committed to pursuing justice on your behalf.
Contact Shamis Gentile PA today for a free consultation regarding your Oxbryta case. We represent clients nationwide and work on a contingency basis, meaning you pay nothing unless we win your case.